• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Second trimester growth velocities: assessment of fetal growth potential in SGA singletons.孕中期生长速度:评估小于胎龄单胎胎儿的生长潜力
J Matern Fetal Neonatal Med. 2019 Mar;32(6):939-946. doi: 10.1080/14767058.2017.1395849. Epub 2017 Nov 7.
2
Can growth in dichorionic twins be monitored with individualized growth assessment?双绒毛膜双胎的生长情况能否通过个体化生长评估进行监测?
Ultrasound Obstet Gynecol. 2023 Dec;62(6):829-835. doi: 10.1002/uog.26320.
3
Third trimester growth restriction patterns: individualized assessment using a fetal growth pathology score.孕晚期生长受限模式:使用胎儿生长病理学评分进行个体化评估。
J Matern Fetal Neonatal Med. 2018 Aug;31(16):2155-2163. doi: 10.1080/14767058.2017.1337741. Epub 2017 Jul 6.
4
Fetal growth pathology score: a novel ultrasound parameter for individualized assessment of third trimester growth abnormalities.胎儿生长病理评分:一种用于个体化评估孕晚期生长异常的新型超声参数。
J Matern Fetal Neonatal Med. 2018 Apr;31(7):866-876. doi: 10.1080/14767058.2017.1300646. Epub 2017 Mar 20.
5
Individualized growth assessment in pregnancies complicated by fetal gastroschisis.胎儿脐膨出妊娠的个体化生长评估。
J Matern Fetal Neonatal Med. 2022 Dec;35(25):6842-6852. doi: 10.1080/14767058.2021.1926976. Epub 2021 Jun 7.
6
Growth patterns and cardiovascular abnormalities in SGA fetuses: 2. Normal growth and progressive growth restriction.小于胎龄儿(SGA)胎儿的生长模式与心血管异常:2. 正常生长与进行性生长受限
J Matern Fetal Neonatal Med. 2022 Jul;35(14):2818-2827. doi: 10.1080/14767058.2020.1807506. Epub 2020 Sep 13.
7
Second- to third-trimester longitudinal growth assessment for prediction of small-for-gestational age and late fetal growth restriction.中孕期至晚孕期的纵向生长评估预测小于胎龄儿及早产儿生长受限。
Ultrasound Obstet Gynecol. 2018 Feb;51(2):219-224. doi: 10.1002/uog.17471. Epub 2018 Jan 8.
8
Second-trimester growth velocities in twin and singleton pregnancies.中孕期双胎和单胎妊娠的生长速度。
Ultrasound Obstet Gynecol. 2023 Jan;61(1):33-39. doi: 10.1002/uog.26102.
9
The effect of maternal body mass index on fetal growth: use of individualized growth assessment and two-level linear modeling.母亲体重指数对胎儿生长的影响:个体化生长评估与二级线性模型的应用
J Clin Ultrasound. 2014 Oct;42(8):456-64. doi: 10.1002/jcu.22158. Epub 2014 May 2.
10
Classifying neonatal growth outcomes: use of birth weight, placental evaluation and individualized growth assessment.新生儿生长结局的分类:出生体重、胎盘评估及个体化生长评估的应用
J Matern Fetal Neonatal Med. 2016 Dec;29(24):3939-49. doi: 10.3109/14767058.2016.1157576. Epub 2016 Mar 21.

引用本文的文献

1
Ultrasound parameters of arteries and heart in normal fetuses.正常胎儿的动脉和心脏的超声参数。
Cardiovasc Ultrasound. 2024 Jul 29;22(1):9. doi: 10.1186/s12947-024-00328-w.
2
Maternal plasma syndecan-1: a biomarker for fetal growth restriction.母体血浆 syndecan-1:胎儿生长受限的生物标志物。
J Matern Fetal Neonatal Med. 2023 Dec;36(1):2150074. doi: 10.1080/14767058.2022.2150074.
3
Fetal growth velocity references from a Chinese population-based fetal growth study.基于中国人群胎儿生长研究的胎儿生长速度参考值。
BMC Pregnancy Childbirth. 2021 Oct 9;21(1):688. doi: 10.1186/s12884-021-04149-x.
4
Longitudinal study on steroid hormone variations during the second trimester of gestation: a useful tool to confirm adequate foetal development.孕期中期类固醇激素变化的纵向研究:确认胎儿发育正常的有用工具。
BMC Pregnancy Childbirth. 2021 Feb 9;21(1):120. doi: 10.1186/s12884-021-03617-8.
5
Individualized growth assessment: conceptual framework and practical implementation for the evaluation of fetal growth and neonatal growth outcome.个体化生长评估:胎儿生长和新生儿生长结局评估的概念框架与实际应用。
Am J Obstet Gynecol. 2018 Feb;218(2S):S656-S678. doi: 10.1016/j.ajog.2017.12.210.

本文引用的文献

1
Third trimester growth restriction patterns: individualized assessment using a fetal growth pathology score.孕晚期生长受限模式:使用胎儿生长病理学评分进行个体化评估。
J Matern Fetal Neonatal Med. 2018 Aug;31(16):2155-2163. doi: 10.1080/14767058.2017.1337741. Epub 2017 Jul 6.
2
Fetal growth pathology score: a novel ultrasound parameter for individualized assessment of third trimester growth abnormalities.胎儿生长病理评分:一种用于个体化评估孕晚期生长异常的新型超声参数。
J Matern Fetal Neonatal Med. 2018 Apr;31(7):866-876. doi: 10.1080/14767058.2017.1300646. Epub 2017 Mar 20.
3
Classifying neonatal growth outcomes: use of birth weight, placental evaluation and individualized growth assessment.新生儿生长结局的分类:出生体重、胎盘评估及个体化生长评估的应用
J Matern Fetal Neonatal Med. 2016 Dec;29(24):3939-49. doi: 10.3109/14767058.2016.1157576. Epub 2016 Mar 21.
4
INTERGROWTH-21st vs customized birthweight standards for identification of perinatal mortality and morbidity.INTERGROWTH-21st标准与定制出生体重标准用于围产期死亡率和发病率的识别比较
Am J Obstet Gynecol. 2016 Apr;214(4):509.e1-509.e7. doi: 10.1016/j.ajog.2015.10.931. Epub 2015 Nov 4.
5
Personalized third-trimester fetal growth evaluation: comparisons of individualized growth assessment, percentile line and conditional probability methods.个性化孕晚期胎儿生长评估:个体化生长评估、百分位数线法和条件概率法的比较
J Matern Fetal Neonatal Med. 2016;29(2):177-85. doi: 10.3109/14767058.2014.995083. Epub 2015 Sep 25.
6
International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project.基于系列超声测量的胎儿生长国际标准:INTERGROWTH-21st 项目胎儿生长纵向研究。
Lancet. 2014 Sep 6;384(9946):869-79. doi: 10.1016/S0140-6736(14)61490-2.
7
A modified prenatal growth assessment score for the evaluation of fetal growth in the third trimester using single and composite biometric parameters.一种改良的产前生长评估评分,用于使用单一和复合生物测量参数评估孕晚期胎儿生长情况。
J Matern Fetal Neonatal Med. 2015 May;28(7):745-54. doi: 10.3109/14767058.2014.934218. Epub 2014 Jul 11.
8
Fetal growth cessation in late pregnancy: its impact on predicted size parameters used to classify small for gestational age neonates.妊娠晚期胎儿生长停止:其对用于分类小于胎龄新生儿的预测大小参数的影响。
J Matern Fetal Neonatal Med. 2015 May;28(7):755-65. doi: 10.3109/14767058.2014.934219. Epub 2014 Jul 11.
9
Individualized fetal growth assessment: critical evaluation of key concepts in the specification of third trimester size trajectories.个体化胎儿生长评估:对孕晚期大小轨迹规范中关键概念的批判性评价
J Matern Fetal Neonatal Med. 2014 Apr;27(6):543-51. doi: 10.3109/14767058.2013.833904. Epub 2013 Sep 12.
10
Assessing the value of customized birth weight percentiles.评估定制出生体重百分位的价值。
Am J Epidemiol. 2011 Feb 15;173(4):459-67. doi: 10.1093/aje/kwq399. Epub 2010 Dec 6.

孕中期生长速度:评估小于胎龄单胎胎儿的生长潜力

Second trimester growth velocities: assessment of fetal growth potential in SGA singletons.

作者信息

Deter Russell L, Lee Wesley, Kingdom John, Romero Roberto

机构信息

a Department of Obstetrics and Gynecology , Texas Children's Hospital, Baylor College of Medicine , Houston , TX , USA.

b Perinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research , Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health , Bethesda , MD and Detroit , MI , USA.

出版信息

J Matern Fetal Neonatal Med. 2019 Mar;32(6):939-946. doi: 10.1080/14767058.2017.1395849. Epub 2017 Nov 7.

DOI:10.1080/14767058.2017.1395849
PMID:29057683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5938145/
Abstract

OBJECTIVE

To evaluate the validity of second trimester growth velocities as measures of fetal growth potential in Small-for-Gestational-Age (SGA) singletons.

METHODS

Second trimester growth velocities for biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC) and femur diaphysis length (FDL) were determined by linear regression analysis or direct measurement in 53 SGA singletons with normal growth outcomes (SGA N Group) and 73 with growth restriction (SGA GR) based on a composite fetal growth pathology score (FGPS1). The latter were subdivided into six groups based on their growth restriction pattern (Patterns group). Similar data were available for 118 singletons with normal neonatal growth outcomes (NNGO group). Coefficients of determination (R) and growth velocities for each anatomical parameter were compared between Patterns subgroups and the SGA N, SGA GR and NNGO groups.

RESULTS

Median R values in the six Patterns subgroups ranged from 98.2% (Pattern 2, FDL) to 99.9% (Pattern 5, AC). Within each anatomical parameter set, no significant differences were found (Kruskal-Wallis). Patterns subgroup data were pooled to form the SGA GR group for each anatomical parameter. Mean values for the three main groups ranged from 98.4% (SGA N, FDL) to 99.6% (SGA N, HC). No significant differences between groups (ANOVA) were found for any anatomical parameter (ANOVA). Only 1.7-3.8% had R values <95th%. No significant differences in median second trimester growth velocities among different Patterns subgroups were found for any anatomical parameter. In the SGA N and SGA GR groups, mean BPD and HC values did not differ but were significantly smaller than the NNGO group values. No differences in mean FDL values were seen. With AC, all three means were significantly different, having the following order: NNGO > SGA N > SGA GR. Of all 504 second trimester growth rates, 92.5% were within their respective 95% reference ranges.

CONCLUSION

Growth in the second trimester is linear in fetuses at risk for growth restriction. Except for FDL, growth velocities were lower than those for fetuses with NNGO. Only AC had mean velocities that differed between the SGA N and the SGA GR groups. Since most velocities (92.5%) were within normal reference ranges, they are reasonable measures of growth potential in fetuses at risk for growth restriction.

摘要

目的

评估孕中期生长速度作为小于胎龄(SGA)单胎胎儿生长潜能指标的有效性。

方法

通过线性回归分析或直接测量,确定了53例生长结局正常的SGA单胎(SGA N组)和73例基于综合胎儿生长病理评分(FGPS1)存在生长受限的SGA单胎(SGA GR组)的孕中期双顶径(BPD)、头围(HC)、腹围(AC)和股骨干长度(FDL)的生长速度。后者根据其生长受限模式分为六个组(模式组)。118例新生儿生长结局正常的单胎(NNGO组)也有类似数据。比较了模式亚组与SGA N组、SGA GR组和NNGO组之间各解剖参数的决定系数(R)和生长速度。

结果

六个模式亚组的中位数R值范围为98.2%(模式2,FDL)至99.9%(模式5,AC)。在每个解剖参数组内,未发现显著差异(Kruskal-Wallis检验)。将模式亚组数据合并形成每个解剖参数的SGA GR组。三个主要组的平均值范围为98.4%(SGA N组,FDL)至99.6%(SGA N组,HC)。对于任何解剖参数,各组之间均未发现显著差异(方差分析)。只有1.7 - 3.8%的R值<第95百分位数。对于任何解剖参数,不同模式亚组之间的孕中期生长速度中位数均未发现显著差异。在SGA N组和SGA GR组中,平均BPD和HC值无差异,但显著小于NNGO组的值。FDL平均值未见差异。对于AC,三个平均值均有显著差异,顺序如下:NNGO>SGA N>SGA GR。在所有504个孕中期生长率中,92.5%在各自的95%参考范围内。

结论

生长受限风险胎儿在孕中期的生长呈线性。除FDL外,生长速度低于新生儿生长结局正常的胎儿。只有AC在SGA N组和SGA GR组之间的平均速度存在差异。由于大多数速度(92.5%)在正常参考范围内,它们是生长受限风险胎儿生长潜能的合理指标。